Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • S. Kommoss - (Author)
  • B. Winterhoff - (Author)
  • A.L. Oberg - (Author)
  • G.E. Konecny - (Author)
  • C. Wang - (Author)
  • S.M. Riska - (Author)
  • J.B. Fan - (Author)
  • M.J. Maurer - (Author)
  • C. April - (Author)
  • V. Shridhar - (Author)
  • F. Kommoss - (Author)
  • A. Du Bois - (Author)
  • F. Hilpert - (Author)
  • S. Mahner - (Author)
  • K. Baumann - (Author)
  • W. Schroeder - (Author)
  • A. Burges - (Author)
  • U. Canzler - , Department of Gynecology and Obstetrics (Author)
  • J. Chien - (Author)
  • A.C. Embleton - (Author)
  • M. Parmar - (Author)
  • R. Kaplan - (Author)
  • T. Perren - (Author)
  • L.C. Hartmann - (Author)
  • E.L. Goode - (Author)
  • S.C. Dowdy - (Author)
  • J. Pfisterer - (Author)

Details

Original languageEnglish
Pages (from-to)3794-3801
Number of pages8
JournalClinical Cancer Research
Publication statusPublished - 2017
Peer-reviewedYes

External IDs

Scopus 85024105263

Keywords

Sustainable Development Goals